Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saliactive is a proprietary oral care composition developed by Mucosa Innovations, consisting of a combination of olive oil, betaine, and xylitol. It is designed to address oral dysbiosis and gingivitis by promoting a state of eubiosis within the oral microbiome, maintaining physiological pH, and reducing inflammation. Olive oil provides antioxidant properties, betaine acts as an osmoprotectant to hydrate and protect the oral mucosa, and xylitol inhibits the growth of cariogenic bacteria such as *Streptococcus mutans*. The composition is delivered via specialized oral hygiene products, such as the YOTUEL microbiome toothpaste, and has been evaluated in clinical trials for its ability to modulate the oral microbiome and reduce pro-inflammatory markers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Saliactive.